Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000178623 | SCV000230738 | uncertain significance | not provided | 2015-01-20 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001082971 | SCV000651178 | likely benign | Myofibrillar myopathy 5; Distal myopathy with posterior leg and anterior hand involvement; Hypertrophic cardiomyopathy 26; Dilated Cardiomyopathy, Dominant | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000178623 | SCV000981456 | benign | not provided | 2020-11-12 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002408773 | SCV002669405 | likely benign | Cardiovascular phenotype | 2019-02-01 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
CHEO Genetics Diagnostic Laboratory, |
RCV003150053 | SCV003838454 | benign | Cardiomyopathy | 2021-09-14 | criteria provided, single submitter | clinical testing |